Patents by Inventor Chuanteng Sun

Chuanteng Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 13-oxidized ingenol derivative and use thereof
    Patent number: 11753363
    Abstract: The present invention relates to a derivative of 13-oxidized ingenol, use thereof in the prevention and/or treatment of a disease associated with proliferation or tumor in a subject, or a cosmetic indication, and use thereof in the prevention and/or treatment of a disease responsive to neutrophil oxidative burst, a disease responsive to a release of IL-8 by keratinocyte, or a disease responsive to induction of necrosis.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: September 12, 2023
    Assignee: Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd. Traditional Chinese Medicine Research Institute
    Inventors: Xiao Wu, Qin Pan, Yanyun Li, Yu Yang, Yuzhen Guan, Xiaolei Wu, Chuanteng Sun, Yuan Wang
  • 13-OXIDIZED INGENOL DERIVATIVE AND USE THEREOF
    Publication number: 20210147334
    Abstract: The present invention relates to a derivative of 13-oxidized ingenol, use thereof in the prevention and/or treatment of a disease associated with proliferation or tumor in a subject, or a cosmetic indication, and use thereof in the prevention and/or treatment of a disease responsive to neutrophil oxidative burst, a disease responsive to a release of IL-8 by keratinocyte, or a disease responsive to induction of necrosis.
    Type: Application
    Filed: June 7, 2018
    Publication date: May 20, 2021
    Applicant: Tianjin Zhongxin Pharmaceutical Group Corp., LTD. Research Institute Branch Company
    Inventors: Xiao Wu, Qin Pan, Yanyun Li, Yu Yang, Yuzhen Guan, Xiaolei Wu, Chuanteng Sun, Yuan Wang
  • 13-OXIDIZED INGENOL DERIVATIVE AND USE THEREOF
    Publication number: 20200140369
    Abstract: The present invention relates to a derivative of 13-oxidized ingenol, use thereof in the prevention and/or treatment of a disease associated with proliferation or tumor in a subject, or a cosmetic indication, and use thereof in the prevention and/or treatment of a disease responsive to neutrophil oxidative burst, a disease responsive to a release of IL-8 by keratinocyte, or a disease responsive to induction of necrosis.
    Type: Application
    Filed: June 7, 2018
    Publication date: May 7, 2020
    Applicant: Tianjin Zhongxin Pharmaceutical Group Corp., LTD. Research Institute Branch Company
    Inventors: Xiao Wu, Qin Pan, Yanyun Li, Yu Yang, Yuzhen Guan, Xioalei Wu, Chuanteng Sun, Yuan Wang